April 1st, 2022 by Jonathan Vande Geest
Prof. Vande Geest and Dr. Behranzade, along with co-founders Dr. John Pacella and Dr. William R. Wagner have co-founded EV2 Technologies to translate the Biocarpet to eventual clinical practice. EV2 will continue to seek non dilutive funding to further develop this technology and prepare for in-vivo assessment.
Posted in Uncategorized